Results of switching to milnacipran in fibromyalgia patients with an inadequate response to duloxetine: a phase IV pilot study

por Bateman, Lucinda, Palmer, Robert H, Trugman, Joel M, Lin, Yuhua
Publicado 2013

Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program

por Arnold, Lesley M., Bateman, Lucinda, Palmer, Robert H., Lin, Yuhua
Publicado 2015

Effect of milnacipran on body weight in patients with fibromyalgia

por Arnold, Lesley M, Palmer, Robert H, Hufford, Michael R, Chen, Wei
Publicado 2012

Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial

por Clauw, Daniel J, Mease, Philip J, Palmer, Robert H, Trugman, Joel M, Wang, Yong
Publicado 2013

Efficacy of long-term milnacipran treatment in patients meeting different thresholds of clinically relevant pain relief: subgroup analysis of a randomized, double-blind, placebo-co...

por Mease, Philip J, Clauw, Daniel J, Trugman, Joel M, Palmer, Robert H, Wang, Yong
Publicado 2014

Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension

por Aman, Michael G., Findling, Robert L., Hardan, Antonio Y., Hendren, Robert L., Melmed, Raun D., Kehinde-Nelson, Ola, Hsu, Hai-An, Trugman, Joel M., Palmer, Robert H., Graham, Stephen M., Gage, Allyson T., Perhach, James L., Katz, Ephraim
Publicado 2017

Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies

por Hardan, Antonio Y, Hendren, Robert L, Aman, Michael G, Robb, Adelaide, Melmed, Raun D, Andersen, Kristen A, Luchini, Rachel, Rahman, Rezwanur, Ali, Sanjida, Jia, X Daniel, Mallick, Madhuja, Lateiner, Jordan E, Palmer, Robert H, Graham, Stephen M
Publicado 2019